The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 4 of 15
intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)
NCT05689502
Trial of Exercise in Aortic Dissection Survivors
NCT05610462
ViDES Trial (Vitamin D Extra Supplementation)
NCT05459298
Video-based Intervention to Address Disparities in Blood Pressure Control After Stroke
NCT05264298
Building Resilience In Caregivers of Trauma Survivors
NCT04293016
Treatment of Occult Inguinal Hernias
NCT04815707
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
NCT04920097
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
NCT04584983
Fetoscopic NEOX Cord 1K® Spina Bifida Repair
NCT04243889
Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2
NCT06082882
Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
NCT07136324
Autologous Stem Cell Study for Adult TBI (Phase 2b)
NCT02525432
Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression
NCT02046330
Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
NCT00913471
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease
NCT00756379
Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)
NCT00178659
Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-center Stepped Wedge Cluster Randomized Study
NCT04200729
Improving HIV Prevention and Substance Use Post-Sexual Assault Services
NCT07225062
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults
NCT07682740
Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
NCT01315782
BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)
NCT07659743
Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT)
NCT07396974
Collagenase Injection for Contracture Management
NCT07693556
Collagenase Injection for Spasticity Management
NCT07693569
Evaluating an Implementation Strategy to Improve Physical Activity and Reduce Cardiovascular Risk Factors in Children
NCT07541118
Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families
NCT07170163
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults (Discovery)
NCT07682727
Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder Mistreatment
NCT07648238
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
NCT07606742
Evaluation of Hypersensitivity Reactions to Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh in Shoulder Surgery
NCT07573202
Virtually Assisted Home Rehabilitation After Stroke for Underserved Texas Communities
NCT07597226
Reduce Inefficiencies in Management of Spasticity
NCT07639632
Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment
NCT07638748
Continuous Versus Intermittent Ward Monitoring
NCT06232876
Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department
NCT07525076
Using an Innovative Implementation Strategy to Increase the Translation of Effective Youth Violence Prevention Programs in Schools
NCT07223957
Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (Pilot)
NCT07396935
Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause
NCT07408440
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
NCT07112365
Dynamic Effect of Occlusal Vertical Dimension on Lower Facial Form and Lip Positions
NCT07491640
Vaginal Natural Orifice Transluminal Endoscopic (vNOTE) Hysterectomy With Uterosacral Suspension
NCT07413861
Effects of a Mobile App-Based Mindfulness Intervention in Persons with Spinal Cord Injury and Chronic Pain
NCT06891989
Characterization of Skin and Facial Fat Pad Thickness Changes Following Microneedling Radiofrequency With and Without Topical Poly-L-Lactic Acid for Facial Rejuvenation
NCT07261527
Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.
NCT04105907
Clinical Language Evaluation With AI for Residents
NCT07222644
Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting
NCT07498153
Produce Rx in High Risk Pregnant Mothers at Harris Health
NCT07165990
Stress Inoculation Training (SIT): An Evidence-Based, Military Aligned Psychological Performance and Health Sustainment Prototype
NCT06656780
Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures
NCT06947902
Effect of Albumin Versus Routine Care on Hemodynamic Response and Stability in Patients With Preeclampsia Guided by a Non-invasive Hemodynamic Monitoring System During Cesarean Delivery With Spinal Anesthesia
NCT06107335
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets.Report a data error.